Aurintricarboxylic Acid CAS: 4431-00-9
MF: C22H14O9
MW: 422.34
A cell-permeable apoptosis inhibitor.

Aurintricarboxylic Acid (CAS 4431-00-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 130ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Aurintricarboxylic Acid is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Nomes alternativos: ATA; 5-[(3-carboxy-4-hydroxyphenyl)-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxybenzoic acid
Aplicação Aurintricarboxylic Acid is a cell-permeable apoptosis inhibitor
Numero VAT: 4431-00-9
Privada: ≥85%
Peso Molecular: 422.34
Separar por Funcao: C22H14O9
Para uso em exclusivo em pesquisa. Não se destina a uso em diagnostico e tratamento.
* Refere-se a Certificado de Análise para data especifica de lotes (incluindo-se o conteúdo de agua).

Aurintricarboxylic Acid a cell-permeable polyanionic, polyaromatic compound employed as a powerful inhibitor of cellular processes, including apoptosis, that are dependent on the formation of protein-nucleic acid complexes. It binds to a FGF and reduces its angiogenic activity. Aurintricarboxylic Acid has been shown to inhibit apoptotic cell death in various cell types induced by a variety of factors. It has also been demonstrated to be a potent inhibitor of DNA topoisomerase II (IC50= 75 nM for the yeast enzyme as measured by relaxation assays) that inhibits angiogenesis. Aurintricarboxylic Acid inhibits von Willebrand factor binding to platelets and reduces glutamate-induced neuronal injury. Aurintricarboxylic Acid also stimulates the tyrosine phosphorylation of MAP kinases, Shc proteins, phosphatidylinositol 3-kinase, and phospholipase Cγ and inhibits both major calpain isoforms (IC50 = 22 µM and IC50 = 10 μM for μ-calpain and m-calpain, respectively).


Referencias

1. Sarma, M.H., et al. 1976. Biochim. Biophys. Acta. 418: 29-38. PMID: 1244850
2. González, R.G., et al. 1980. Biochemistry. 19: 4299-4303. PMID: 6158332
3. Posner, A., et al. 1995. Biochem. Mol. Biol. Int. 36: 291-299. PMID: 7663433
4. Benchokroun, Y., et al. 1995. Biochem. Pharmacol. 49: 305-313. PMID: 7857317
5. Okada, N., et al. 1995. J. Biol. Chem. 270: 16464-16469. PMID: 7608219
6. Okada, N., et al. 1997. Biochem. Biophys. Res. Commun. 230: 266-269. PMID: 9016763
7. Rui, H., et al. 1998. J. Biol. Chem. 273: 28-32. PMID: 9417042
8. Aronica, E.M., et al. 1998. Proc. Natl. Acad. Sci. U.S.A. 95: 7115-7120. PMID: 9618548

Aparência :
Powder
Estado físico :
Solid
envie :
Soluble in water (7 mg/mL), 1 M NH4OH (10 mg/mL), ethanol (60 mg/mL), 0.1 M NaOH (35 mg/mL), and aqueous alkali.
Manutencao :
Store at room temperature
Ponto de fusão :
300° C (lit.)
Ponto de fervura :
759.64° C at 760 mmHg (Predicted)
Densidade :
1.6 g/cm3 (Predicted)
Indice de produtos :
n20D 1.75 (Predicted)
IC50 :
DNA topoisomerase II: IC50 = 75 nM; -calpain: IC50 = 22 µM; m-calpain: IC50 = 10 µM; MT4 : IC50 = 0.5 µg/mL (human); CEM : IC50 = 1.2 µg/mL (human); Human immunodeficiency virus 1: EC5050 = 76 nM
Valores de pK :
pKa: 2.20 (Predicted)
Para uso em exclusivo em pesquisa. Não se destina a uso em diagnostico e tratamento.
WGK Alemanha :
3
RTECS :
GU4790000
PubChem CID :
2259
Numero de FAX :
MFCD00011663
Numero de FAX :
224-628-1
Registro Beilstein :
2228904
SMILES :
C1=CC(=C(C=C1C(=C2C=CC(=O)C(=C2)C(=O)O)C3=CC(=C(C=C3)O)C(=O)O)C(=O)O)O

Baixar SDS (MSDS)

Certificado de Análise

É necessário o Adobe Acrobat Reader para visualizar corretamente,
imprimir e comentar os documentos PDF

Aurintricarboxylic Acid (CAS 4431-00-9)  Citacoes dos Produtos

Visualizar com outras pessoas usaram Aurintricarboxylic Acid (CAS 4431-00-9). Clique em PubMed para ver .

Citações 1 para 10 de 11 total

PMID: # 28223427  Noguchi, F. et al. 2017. Mol. Cancer Ther. 16: 936-947.

PMID: # 20006589  Dejeans, N. et al. 2010. Biochem. Pharmacol. 79: 1221-30.

PMID: # 19340923  Kodama, Y. et al. 2009. Biochimie. -.

PMID: # 16806822  El Kebir, D. et al. 2006. Cell. Signal. 18: 2302-2313.

PMID: # 16928960  Robert, F. et al. 2006. Mol. Biol. Cell. 17: 4632-4644.

PMID: # 16822833  Schaletzky, J. et al. 2006. Mol. Biol. Cell. 17: 3860-3869.

PMID: # 16246361  Takaya, N. et al. 2005. J. Mol. Cell. Cardiol. 39: 856-864.

PMID: # 15671063  Ma, R. Y. M. et al. 2005. J Cell Sci. 118: 795-806.

PMID: # 11099777  Cavaliere, F. et al. 2001. Neurochem. Int. 38: 199-207.

PMID: # 9795126  Solovyan, V. et al. 1998. Brain Res. Mol. Brain Res. 62: 43-55.

Citações 1 para 10 de 11 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 160ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 11ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

A Santa Cruz Biotecnologia, Inc. é a líder mundial no desenvolvimento de produtos para o mercado de pesquisa biomédica. Ligue para nós ligação gratuita 1-800-457-3801..
Direito de Reprodução© 2007-2020 Santa Cruz Biotechnology, Inc. Todos os direitos reservados. "Santa Cruz Biotechnology", Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", "EZ Touch" são marcas registradas da Santa Cruz Biotechnology, Inc. Todas as marcas registradas são propriedade dos seus respectivos donos.